• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, February 7, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News

Funding for French-German research project on quantum technology

Bioengineer by Bioengineer
November 2, 2022
in Science News
Reading Time: 2 mins read
0
Sören Petrat, Professor of Mathematics at Jacobs University Bremen
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

The Royal Swedish Academy of Sciences in Stockholm awarded this year’s Nobel Prize in Physics for groundbreaking work in this field. In highly complex quantum physics, two or more particles can be entangled and thus dependent on each other. What happens to one of the particles in an entangled pair determines what happens to the other particle, even if both particles are far apart.

Sören Petrat, Professor of Mathematics at Jacobs University Bremen

Credit: Jacobs University Bremen

The Royal Swedish Academy of Sciences in Stockholm awarded this year’s Nobel Prize in Physics for groundbreaking work in this field. In highly complex quantum physics, two or more particles can be entangled and thus dependent on each other. What happens to one of the particles in an entangled pair determines what happens to the other particle, even if both particles are far apart.

This phenomenon of entanglement has to be controlled, because it causes the equations describing realistic quantum systems to become far too complicated to solve analytically or numerically. Simpler, so-called effective equations provide a remedy. “If I want to describe a gas or simply the air in a room, I’m usually not interested in the motion of each individual atom. Instead, I’m interested in quantities like temperature, pressure, or volume. These are all examples of effective quantities-” Petrat puts it into simple words.

In the research project, the team is mathematically investigating ultracold gases near the absolute zero of minus 273.15 degrees Celsius – so-called cold Fermi and Bose gases, whose properties are used in quantum technology. “Our goal is to rigorously derive such effective equations mathematically,” Petrat said. These equations, for example, are indispensable for quantum computers. “For me, this is a very exciting area of research because there is an extreme amount of progress currently coming together in three areas: experimental physics, theoretical physics and mathematics.”

Five scientists from four universities are involved in the research project entitled “Effective approximation and dynamics of many-body quantum systems.” In addition to Sören Petrat, these are Professor Volker Bach, mathematical physicist at TU Braunschweig, and the mathematicians Professor Sébastien Breteaux and Professor Jérémy Faupin from the Université de Lorraine and Professor Zied Ammari from the Université de Rennes. “We are very pleased to be able to continue the long and successful Franco-German collaboration on this topic with this funding,” Petrat said.

About Jacobs University Bremen:
Studying in an international community. Obtaining a qualification to work on responsible tasks in a digitized and globalized society. Learning, researching and teaching across academic disciplines and countries. Strengthening people and markets with innovative solutions and advanced training programs. This is what Jacobs University Bremen stands for. Established as a private, English-medium campus university in Germany in 2001, it is continuously achieving top results in national and international university rankings. Its more than 1,600 students come from more than 110 countries with around 80% having relocated to Germany for their studies. Jacobs University’s research projects are funded by the German Research Foundation or the EU Research and Innovation program as well as by globally leading companies.
For more information: www.jacobs-university.de
Facebook | Youtube | Twitter | Instagram | LinkedIn



Share12Tweet8Share2ShareShareShare2

Related Posts

Oxygen-Enhanced Dual-Section Microneedle Patch Improves Drug Delivery and Boosts Photodynamic and Anti-Inflammatory Treatment for Psoriasis

February 7, 2026

Scientists Identify SARS-CoV-2 PLpro and RIPK1 Inhibitors Showing Potent Synergistic Antiviral Effects in Mouse COVID-19 Model

February 7, 2026

Neg-Entropy: The Key Therapeutic Target for Chronic Diseases

February 7, 2026

Multidisciplinary Evidence-Based Guidelines for Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease

February 7, 2026

POPULAR NEWS

  • Robotic Ureteral Reconstruction: A Novel Approach

    Robotic Ureteral Reconstruction: A Novel Approach

    82 shares
    Share 33 Tweet 21
  • Digital Privacy: Health Data Control in Incarceration

    63 shares
    Share 25 Tweet 16
  • Study Reveals Lipid Accumulation in ME/CFS Cells

    57 shares
    Share 23 Tweet 14
  • Breakthrough in RNA Research Accelerates Medical Innovations Timeline

    53 shares
    Share 21 Tweet 13

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Oxygen-Enhanced Dual-Section Microneedle Patch Improves Drug Delivery and Boosts Photodynamic and Anti-Inflammatory Treatment for Psoriasis

Scientists Identify SARS-CoV-2 PLpro and RIPK1 Inhibitors Showing Potent Synergistic Antiviral Effects in Mouse COVID-19 Model

Neg-Entropy: The Key Therapeutic Target for Chronic Diseases

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 73 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.